199 related articles for article (PubMed ID: 24190638)
1. Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors.
Virág J; Kenessey I; Haberler C; Piurkó V; Bálint K; Döme B; Tímár J; Garami M; Hegedűs B
Pathol Oncol Res; 2014 Apr; 20(2):417-26. PubMed ID: 24190638
[TBL] [Abstract][Full Text] [Related]
2. Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors.
Puputti M; Tynninen O; Pernilä P; Salmi M; Jalkanen S; Paetau A; Sihto H; Joensuu H
Brain Pathol; 2010 Jul; 20(4):763-70. PubMed ID: 20030644
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors.
Tamura R; Sato M; Morimoto Y; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Murase M; Yoshida K; Toda M
Exp Mol Pathol; 2020 Jun; 114():104408. PubMed ID: 32088190
[TBL] [Abstract][Full Text] [Related]
4. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
5. The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
Jansson S; Bendahl PO; Grabau DA; Falck AK; Fernö M; Aaltonen K; Rydén L
PLoS One; 2014; 9(7):e102176. PubMed ID: 25025175
[TBL] [Abstract][Full Text] [Related]
6. Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma.
Moreno L; Popov S; Jury A; Al Sarraj S; Jones C; Zacharoulis S
J Neurooncol; 2013 Jan; 111(2):169-76. PubMed ID: 23135775
[TBL] [Abstract][Full Text] [Related]
7. Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
Sie M; den Dunnen WF; Lourens HJ; Meeuwsen-de Boer TG; Scherpen FJ; Zomerman WW; Kampen KR; Hoving EW; de Bont ES
PLoS One; 2015; 10(3):e0122555. PubMed ID: 25799134
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
10. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.
Welin S; Fjällskog ML; Saras J; Eriksson B; Janson ET
Neuroendocrinology; 2006; 84(1):42-8. PubMed ID: 17047316
[TBL] [Abstract][Full Text] [Related]
11. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.
Hashimoto A; Tarner IH; Bohle RM; Gaumann A; Manetti M; Distler O; Steinmeyer J; Ulfgren AK; Schulz A; Gay S; Müller-Ladner U; Neumann E
Arthritis Rheum; 2007 Apr; 56(4):1094-105. PubMed ID: 17393418
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
Shibuya M
J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer.
Gockel I; Moehler M; Frerichs K; Drescher D; Trinh TT; Duenschede F; Borschitz T; Schimanski K; Biesterfeld S; Herzer K; Galle PR; Lang H; Junginger T; Schimanski CC
Oncol Rep; 2008 Oct; 20(4):845-50. PubMed ID: 18813825
[TBL] [Abstract][Full Text] [Related]
14. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
Fjällskog ML; Lejonklou MH; Oberg KE; Eriksson BK; Janson ET
Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer.
Schimanski CC; Zimmermann T; Schmidtmann I; Gockel I; Lang H; Galle PR; Moehler M; Berger MR
Int J Colorectal Dis; 2010 Feb; 25(2):181-6. PubMed ID: 19936766
[TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.
Blom T; Roselli A; Häyry V; Tynninen O; Wartiovaara K; Korja M; Nordfors K; Haapasalo H; Nupponen NN
J Neurooncol; 2010 Apr; 97(2):217-24. PubMed ID: 19779861
[TBL] [Abstract][Full Text] [Related]
17. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
Urie BK; Russell DS; Kisseberth WC; London CA
BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
[TBL] [Abstract][Full Text] [Related]
19. Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study.
Lattanzio R; La Sorda R; Facciolo F; Sioletic S; Lauriola L; Martucci R; Gallo E; Palmieri G; Evoli A; Alessandrini G; Ruco L; Rendina EA; Truini M; Chiarle R; Barreca A; Pich A; Ascani S; Remotti D; Tunesi G; Granone P; Ratto GB; Puma F; Pescarmona E; Piantelli M; Marino M; ; Carlini S; Cerasoli V; Corzani F; Melis E; Filippetti M; Canalini P; Palestro G; Lalle M; Ruffini E; Ceribelli A; Rinaldi M
Lung Cancer; 2014 Aug; 85(2):191-6. PubMed ID: 24908332
[TBL] [Abstract][Full Text] [Related]
20. C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.
Harding K; De Mello Souza CH; Shiomitsu K; Maxwell E; Bertran J
Can J Vet Res; 2021 Oct; 85(4):279-284. PubMed ID: 34602732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
